Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06408181
PHASE3

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

Sponsor: University of Pennsylvania

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to investigate the effects of early initiation of double low-dose aspirin in pregnant women. The main questions it aims to answer are: Does this dose and timing of aspirin reduce the risk of pre-eclampsia compared to standard recommendations? Does this dose and timing of aspirin reduce the risk of pregnancy loss compared to standard recommendations? Participants will begin taking at no later than 6 weeks 6 days gestational age, either 162mg of aspirin through delivery or placebo until 12 weeks and then 81mg of aspirin through delivery.

Key Details

Gender

FEMALE

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

1150

Start Date

2024-06-12

Completion Date

2029-06

Last Updated

2026-01-20

Healthy Volunteers

No

Interventions

DRUG

Aspirin 162 mg

Aspirin is a nonsteroidal anti-inflammatory drug.

DRUG

Aspirin 81mg

Aspirin is a nonsteroidal anti-inflammatory drug.

Locations (1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States